$13.80
6.65% yesterday
Nasdaq, Aug 12, 10:00 pm CET
ISIN
ANN6748L1027
Symbol
OFIX

Orthofix International NV Stock price

$13.80
+2.82 25.68% 1M
-4.26 23.59% 6M
-3.66 20.96% YTD
-2.24 13.97% 1Y
-9.03 39.55% 3Y
-20.55 59.83% 5Y
-24.69 64.15% 10Y
-29.20 67.91% 20Y
Nasdaq, Closing price Tue, Aug 12 2025
+0.86 6.65%

Key metrics

Basic
Market capitalization
$511.1m
Enterprise Value
$620.8m
Net debt
$109.7m
Cash
$65.6m
Shares outstanding
39.5m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.6 | 0.6
EV/Sales
0.8 | 0.7
EV/FCF
1,349.4
P/B
1.1
Financial Health
Equity Ratio
56.3%
Return on Equity
-25.0%
ROCE
-13.8%
ROIC
-15.3%
Debt/Equity
0.4
Financials (TTM | estimate)
Revenue
$809.0m | $829.1m
EBITDA
$-64.1m | $84.3m
EBIT
$-95.3m | $-70.9m
Net Income
$-123.7m | $-96.0m
Free Cash Flow
$460.0k
Growth (TTM | estimate)
Revenue
4.8% | 3.7%
EBITDA
19.7% | 296.7%
EBIT
1.8% | -17.7%
Net Income
-2.7% | 23.8%
Free Cash Flow
100.6%
Margin (TTM | estimate)
Gross
67.4%
EBITDA
-7.9% | 10.2%
EBIT
-11.8%
Net
-15.3% | -11.6%
Free Cash Flow
0.1%
More
EPS
$-3.1
FCF per Share
$0.0
Short interest
6.4%
Employees
2k
Rev per Employee
$490.0k
Show more

Is Orthofix International NV a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Orthofix International NV Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Orthofix International NV forecast:

9x Buy
82%
2x Hold
18%

Analyst Opinions

11 Analysts have issued a Orthofix International NV forecast:

Buy
82%
Hold
18%

Financial data from Orthofix International NV

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
809 809
5% 5%
100%
- Direct Costs 264 264
4% 4%
33%
545 545
5% 5%
67%
- Selling and Administrative Expenses 536 536
3% 3%
66%
- Research and Development Expense 72 72
4% 4%
9%
-64 -64
20% 20%
-8%
- Depreciation and Amortization 31 31
81% 81%
4%
EBIT (Operating Income) EBIT -95 -95
2% 2%
-12%
Net Profit -124 -124
3% 3%
-15%

In millions USD.

Don't miss a Thing! We will send you all news about Orthofix International NV directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Orthofix International NV Stock News

Neutral
The Motley Fool
7 days ago
Orthofix (OFIX) Q2 Revenue Rises 2%
Neutral
Seeking Alpha
7 days ago
Orthofix Medical Inc. (NASDAQ:OFIX ) Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ET Company Participants Julie B. Andrews - Chief Financial Officer Julie D.
Neutral
Business Wire
7 days ago
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the second quarter ended June 30, 2025, and reaffirmed its full-year 2025 financial guidance. All pro forma measures contained within this release exclude the impact of the Company's decision to discontinue its M6® product lines. Highligh...
More Orthofix International NV News

Company Profile

Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment offers three primary product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Bone Growth Therapies product category manufactures, distributes, and provides support services of bone growth stimulator devices that enhance bone fusion. The Spinal Implants product category designs, develops, and markets a broad portfolio of motion preservation and fixation implant products used in surgical procedures of the spine. The Biologics product category provides a portfolio of regenerative products and tissue forms that allow physicians to treat a variety of spinal and orthopedic conditions. The Global Extremities reporting segment offers products and solutions that allow physicians to successfully treat a variety of orthopedic conditions unrelated to the spine. The company was founded on October 19, 1987 and is headquartered in Lewisville, TX.

Head office Curaçao
CEO Massimo Calafiore
Employees 1,616
Founded 1987
Website ir.orthofix.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today